Nothing Special   »   [go: up one dir, main page]

FR2920967B1 - Utilisation de l'hydroxymethionine en tant qu'actif anti age - Google Patents

Utilisation de l'hydroxymethionine en tant qu'actif anti age

Info

Publication number
FR2920967B1
FR2920967B1 FR0757616A FR0757616A FR2920967B1 FR 2920967 B1 FR2920967 B1 FR 2920967B1 FR 0757616 A FR0757616 A FR 0757616A FR 0757616 A FR0757616 A FR 0757616A FR 2920967 B1 FR2920967 B1 FR 2920967B1
Authority
FR
France
Prior art keywords
hydroxymethionine
aging agent
aging
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0757616A
Other languages
English (en)
Other versions
FR2920967A1 (fr
Inventor
Karl Lintner
Chamberlin Claire Mas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sederma SA filed Critical Sederma SA
Priority to FR0757616A priority Critical patent/FR2920967B1/fr
Priority to EP08807602.1A priority patent/EP2209460B1/fr
Priority to PCT/IB2008/053667 priority patent/WO2009034537A2/fr
Priority to US12/733,557 priority patent/US8377663B2/en
Priority to JP2010524614A priority patent/JP5209724B2/ja
Priority to CN200880108024.1A priority patent/CN101854907B/zh
Publication of FR2920967A1 publication Critical patent/FR2920967A1/fr
Application granted granted Critical
Publication of FR2920967B1 publication Critical patent/FR2920967B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0757616A 2007-09-14 2007-09-14 Utilisation de l'hydroxymethionine en tant qu'actif anti age Active FR2920967B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0757616A FR2920967B1 (fr) 2007-09-14 2007-09-14 Utilisation de l'hydroxymethionine en tant qu'actif anti age
EP08807602.1A EP2209460B1 (fr) 2007-09-14 2008-09-11 Composition cosmétique comprenant de l'hydroxyméthionine et de l'acide 3-aminopropanesulfonique
PCT/IB2008/053667 WO2009034537A2 (fr) 2007-09-14 2008-09-11 Composition cosmétique comprenant de l'hydroxyméthionine et de l'acide 3-aminopropanesulfonique
US12/733,557 US8377663B2 (en) 2007-09-14 2008-09-11 Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid
JP2010524614A JP5209724B2 (ja) 2007-09-14 2008-09-11 ヒドロキシメチオニン及び３−アミノプロパンスルホン酸を含む化粧品組成物
CN200880108024.1A CN101854907B (zh) 2007-09-14 2008-09-11 化妆用或皮肤药用的组合物及其用法和化妆方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0757616A FR2920967B1 (fr) 2007-09-14 2007-09-14 Utilisation de l'hydroxymethionine en tant qu'actif anti age

Publications (2)

Publication Number Publication Date
FR2920967A1 FR2920967A1 (fr) 2009-03-20
FR2920967B1 true FR2920967B1 (fr) 2009-10-23

Family

ID=39338384

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0757616A Active FR2920967B1 (fr) 2007-09-14 2007-09-14 Utilisation de l'hydroxymethionine en tant qu'actif anti age

Country Status (6)

Country Link
US (1) US8377663B2 (fr)
EP (1) EP2209460B1 (fr)
JP (1) JP5209724B2 (fr)
CN (1) CN101854907B (fr)
FR (1) FR2920967B1 (fr)
WO (1) WO2009034537A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843023B1 (fr) * 2002-07-30 2004-09-24 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha.
FR2869229B1 (fr) * 2004-04-26 2006-08-25 Sederma Soc Par Actions Simpli Utilisation d'un inducteur des ugt par voie topique
FR2880802B1 (fr) 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
FR2885522B1 (fr) * 2005-05-13 2020-01-10 Sederma Composition cosmetique ou dermopharmaceutique contenant de la teprenone
FR2890310B1 (fr) 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
FR2900573B1 (fr) 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
FR2904549B1 (fr) 2006-08-03 2012-12-14 Sederma Sa Composition comprenant de la sarsasapogenine
GB0910657D0 (en) 2009-06-22 2009-08-05 Unilever Plc Antiperspirant compositions
ES2528495T3 (es) 2010-12-30 2015-02-10 Metabolic Explorer Producción fermentativa de análogo hidroxi de metionina (MHA)
DE102011078952A1 (de) * 2011-07-11 2013-01-17 Henkel Ag & Co. Kgaa Pflegendes kosmetisches Reinigungsmittel mit verbesserten Schaumeigenschaften
WO2013142247A1 (fr) * 2012-03-22 2013-09-26 Precision Dermatology, Inc. Microémulsions à base de cyclodextrine, et leurs utilisations dermatologiques
BR112014029758A2 (pt) 2012-05-30 2017-06-27 Clariant Finance Bvi Ltd composição contendo n-metil-n-acilglucamina
CN104540494B (zh) 2012-05-30 2017-10-24 科莱恩金融(Bvi)有限公司 N‑甲基‑n‑酰基葡糖胺作为增溶剂的用途
JP2014040398A (ja) * 2012-08-23 2014-03-06 Mikimoto Pharmaceut Co Ltd フィラグリン産生促進剤、インボルクリン産生促進剤、ロリクリン産生促進剤、コルネオデスモシン産生促進剤他
DE102012021647A1 (de) 2012-11-03 2014-05-08 Clariant International Ltd. Wässrige Adjuvant-Zusammensetzungen
CN102988199B (zh) * 2012-11-30 2014-05-07 唯美度科技（北京）有限公司 嫩肤抗敏精华液
US9861645B2 (en) 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations
JP2014208597A (ja) * 2013-04-16 2014-11-06 オリザ油化株式会社 爪におけるセラミド含量増加剤
US20160074310A1 (en) * 2013-04-20 2016-03-17 Clariant International Ltd. Composition Containing Oil Bodies, Fatty Acids, Amino Acid Surfactants And N-Methyl-N-Acylglucamines
DE102014005771A1 (de) 2014-04-23 2015-10-29 Clariant International Ltd. Verwendung von wässrigen driftreduzierenden Zusammensetzungen
WO2016076310A1 (fr) * 2014-11-10 2016-05-19 昭和電工株式会社 Agent hydratant
WO2016126886A1 (fr) * 2015-02-04 2016-08-11 Nugene, Inc. Crèmes de traitement de brûlure, de cicatrice et de plaie
KR102359434B1 (ko) * 2015-03-31 2022-02-09 (주)아모레퍼시픽 피부보습용 조성물
JP6666992B2 (ja) * 2015-07-13 2020-03-18 ドクター・レディーズ・ラボラトリーズ・リミテッド 局所用レチノイド組成物
ES2814281T3 (es) * 2015-07-22 2021-03-26 Oreal Composición para limpiar un material queratínico que contiene un tensioactivo de aminoácido
DE202015008045U1 (de) 2015-10-09 2015-12-09 Clariant International Ltd. Universelle Pigmentdispersionen auf Basis von N-Alkylglukaminen
DE102015219651A1 (de) 2015-10-09 2017-04-13 Clariant International Ltd. Zusammensetzungen enthaltend Zuckeramin und Fettsäure
JP6703824B2 (ja) * 2015-11-30 2020-06-03 シスメックス株式会社 細胞選択方法、細胞検出方法、細胞選択装置、および細胞検出装置
DE202016003070U1 (de) 2016-05-09 2016-06-07 Clariant International Ltd. Stabilisatoren für Silikatfarben
GB201611406D0 (en) * 2016-06-30 2016-08-17 Boots Co Plc Skin care composition and method thereof
GB201611413D0 (en) * 2016-06-30 2016-08-17 Boots Co Plc Method of skin care
US11129818B2 (en) 2017-06-07 2021-09-28 Arcutis Biotherapeutics, Inc. Topical roflumilast formulation having improved delivery and plasma half life
US9895359B1 (en) 2017-06-07 2018-02-20 Arcutis, Inc. Inhibition of crystal growth of roflumilast
US20210161870A1 (en) 2017-06-07 2021-06-03 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
US12011437B1 (en) 2017-06-07 2024-06-18 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
WO2019236374A2 (fr) 2018-06-04 2019-12-12 Arcutis, Inc. Méthode et formulation pour améliorer le temps de latence de pénétration de la peau du roflumilast
CA3140814A1 (fr) * 2019-06-24 2020-12-30 Rossana Castellana Formulations pour usage odontologique et dermatologique contenant des sels de trichloroacetate et des hydroxyacides
FR3107120B1 (fr) * 2020-02-07 2022-11-25 Rubix S&I Procédé et système d’étalonnage d’un capteur chimique non sélectif
AU2021268977B2 (en) * 2020-05-07 2024-05-23 Arcutis Biotherapeutics, Inc. Treatment of skin conditions using high Krafft temperature anionic surfactants
CN111973528B (zh) * 2020-08-27 2022-07-01 上海辉文生物技术股份有限公司 一种具有美白抗炎安全不致敏的薯蓣提取物及其制备方法
CN117598924B (zh) * 2023-11-30 2024-06-18 广州市仙迪生物科技有限公司 一种植物多肽组合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
MC2394A1 (fr) * 1995-05-24 1996-07-26 Mollet Marc Composition destinée à stopper la chute et/ou à favoriser
KR0162281B1 (ko) * 1995-10-27 1998-12-01 이능희 타우린 및 아미노프로판 설폰산 또는 그의 염을 함유하는 화장료 조성물
DE10133197A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Aminosäuren enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
US20040126449A1 (en) * 2002-12-30 2004-07-01 Gopa Majmudar Topical composition and methods for treatment of aged or environmentally damaged skin

Also Published As

Publication number Publication date
EP2209460A2 (fr) 2010-07-28
FR2920967A1 (fr) 2009-03-20
JP2010539157A (ja) 2010-12-16
EP2209460B1 (fr) 2017-05-10
US8377663B2 (en) 2013-02-19
US20100285077A1 (en) 2010-11-11
CN101854907A (zh) 2010-10-06
WO2009034537A2 (fr) 2009-03-19
CN101854907B (zh) 2014-06-18
JP5209724B2 (ja) 2013-06-12
WO2009034537A3 (fr) 2010-02-25

Similar Documents

Publication Publication Date Title
FR2920967B1 (fr) Utilisation de l'hydroxymethionine en tant qu'actif anti age
BRPI0906082A2 (pt) "sanitizador hidratante para as mãos"
BRPI0916123A2 (pt) "composição de xampu concentrada"
BRPI0910229A2 (pt) Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos
BR112012007164A2 (pt) "veículo"
BRPI1008178A2 (pt) "descarga de baterias"
FR2951946B1 (fr) Utilisation d'un hydrolysat peptidique de levure en tant qu'agent actif pour renforcer le cheveu
BR112012012872A2 (pt) "pirrolindinas de espiroindolinona"
FR2940290B1 (fr) Agent de couplage mercaptosilane bloque
BRPI0922904A2 (pt) "compostos"
BRPI0913806A2 (pt) "composição"
BRPI1015540A2 (pt) ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750''
BRPI1010761A2 (pt) "composições semi-sólidas e produtos farmacêuticos"
BRPI0907268A2 (pt) "seringa de segurança"
BRPI0812632A2 (pt) de compostos de efluente aquoso"
DK2185142T3 (da) Antiseptiske midler
BRPI0916129A2 (pt) "reforço"
BRPI0914383A2 (pt) "composição de shampoo condicionador"
BRPI0914503A2 (pt) "composição de shampoo concentrado"
BR112012025270A2 (pt) "composição de cuidados pessoais"
DK2237727T3 (da) Vævsretraktor
FR2932986B1 (fr) Composition regeneratrice de la peau
FR2958847B1 (fr) Utilisation d'un hydrolysat peptidique de pois en tant qu'agent actif hydratant
IT1395687B1 (it) Dispositivo per l'applicazione di etichette termoretraibili
FR2945442B1 (fr) Utilisation de delta-tocopheryl-glucide en tant qu'agent depigmentant.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18